Literature DB >> 9762007

Regulation of PTP-1 and insulin receptor kinase by fractions from cinnamon: implications for cinnamon regulation of insulin signalling.

J Imparl-Radosevich1, S Deas, M M Polansky, D A Baedke, T S Ingebritsen, R A Anderson, D J Graves.   

Abstract

Bioactive compound(s) extracted from cinnamon potentiate insulin activity, as measured by glucose oxidation in the rat epididymal fat cell assay. Wortmannin, a potent PI 3'-kinase inhibitor, decreases the biological response to insulin and bioactive compound(s) from cinnamon similarly, indicating that cinnamon is affecting an element(s) upstream of PI 3'-kinase. Enzyme studies done in vitro show that the bioactive compound(s) can stimulate autophosphorylation of a truncated form of the insulin receptor and can inhibit PTP-1, a rat homolog of a tyrosine phosphatase (PTP-1B) that inactivates the insulin receptor. No inhibition was found with alkaline phosphate or calcineurin suggesting that the active material is not a general phosphatase inhibitor. It is suggested, then, that a cinnamon compound(s), like insulin, affects protein phosphorylation-dephosphorylation reactions in the intact adipocyte. Bioactive cinnamon compounds may find further use in studies of insulin resistance in adult-onset diabetes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9762007     DOI: 10.1159/000023270

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  38 in total

1.  Cinnamon as a supplemental treatment for impaired glucose tolerance and type 2 diabetes.

Authors:  Amy D Otto
Journal:  Curr Diab Rep       Date:  2010-06       Impact factor: 4.810

2.  Naphthalenemethyl ester derivative of dihydroxyhydrocinnamic acid, a component of cinnamon, increases glucose disposal by enhancing translocation of glucose transporter 4.

Authors:  W Kim; L Y Khil; R Clark; S H Bok; E E Kim; S Lee; H S Jun; J W Yoon
Journal:  Diabetologia       Date:  2006-08-09       Impact factor: 10.122

Review 3.  Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals.

Authors:  Bharat B Aggarwal
Journal:  Annu Rev Nutr       Date:  2010-08-21       Impact factor: 11.848

Review 4.  Orally active insulin mimics: where do we stand now?

Authors:  M Balasubramanyam; V Mohan
Journal:  J Biosci       Date:  2001-09       Impact factor: 1.826

Review 5.  Alternative and complementary treatments for metabolic syndrome.

Authors:  Mariya Power; Richard Pratley
Journal:  Curr Diab Rep       Date:  2011-06       Impact factor: 4.810

6.  (±)-Diinsininone: made nature's way.

Authors:  Carolyn Selenski; Thomas R R Pettus
Journal:  Tetrahedron       Date:  2006-05-29       Impact factor: 2.457

7.  Novel angiogenesis inhibitory activity in cinnamon extract blocks VEGFR2 kinase and downstream signaling.

Authors:  Jianming Lu; Keqiang Zhang; Sangkil Nam; Richard A Anderson; Richard Jove; Wei Wen
Journal:  Carcinogenesis       Date:  2009-12-07       Impact factor: 4.944

Review 8.  Impact of dietary polyphenols on carbohydrate metabolism.

Authors:  Kati Hanhineva; Riitta Törrönen; Isabel Bondia-Pons; Jenna Pekkinen; Marjukka Kolehmainen; Hannu Mykkänen; Kaisa Poutanen
Journal:  Int J Mol Sci       Date:  2010-03-31       Impact factor: 5.923

Review 9.  Potential therapeutic value of TRPV1 and TRPA1 in diabetes mellitus and obesity.

Authors:  Andrei V Derbenev; Andrea Zsombok
Journal:  Semin Immunopathol       Date:  2015-09-24       Impact factor: 9.623

Review 10.  Complementary and alternative medicine for the treatment of type 2 diabetes.

Authors:  Richard Nahas; Matthew Moher
Journal:  Can Fam Physician       Date:  2009-06       Impact factor: 3.275

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.